{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:20:15Z","timestamp":1761862815306},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.lungcan.2008.11.014","type":"journal-article","created":{"date-parts":[[2009,1,21]],"date-time":"2009-01-21T19:26:10Z","timestamp":1232565970000},"page":"230-236","source":"Crossref","is-referenced-by-count":69,"title":["Polymorphisms in XRCC1 and XPG and response to platinum-based chemotherapy in advanced non-small cell lung cancer patients"],"prefix":"10.1016","volume":"65","author":[{"given":"Xinchen","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Shukui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Baoan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Jifeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Zuhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Hongyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cao","family":"YuanDong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji","family":"Jiazhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhou","family":"Yingfeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2008.11.014_bib1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","article-title":"Cancer Statistics, 2007","volume":"57","author":"Jemal","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.lungcan.2008.11.014_bib2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3322\/canjclin.52.1.23","article-title":"Cancer statistics, 2002","volume":"52","author":"Jemal","year":"2002","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.lungcan.2008.11.014_bib3","first-page":"1087","article-title":"New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: a review of the literature and future directions","volume":"4","author":"Bunn","year":"1998","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.lungcan.2008.11.014_bib4","article-title":"The big lung trial (BLT): determining the value of cisplatin-based chemotherapy for all patients with non-small cell lung cancer (NSCLC)\u2014preliminary results in the supportive care setting","volume":"21","author":"Stephens","year":"2002","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.lungcan.2008.11.014_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2165\/00003495-200059004-00002","article-title":"Clinical perspectives on platinum resistance","volume":"59","author":"Giaccone","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.lungcan.2008.11.014_bib6","series-title":"Cancer: principles and practice of oncology","first-page":"376","article-title":"Cisplatin and its analogues","author":"Johnson","year":"2001"},{"key":"10.1016\/j.lungcan.2008.11.014_bib7","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/PL00000762","article-title":"Carmo-Fonseca M: molecular mechanisms involved in cisplatin cytotoxicity","volume":"57","author":"Jordan","year":"2000","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.lungcan.2008.11.014_bib8","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/(SICI)1097-0215(20000320)89:2<160::AID-IJC10>3.0.CO;2-J","article-title":"DNA-adduct levels as a predictor of outcome for NSCLC patients receiving daily cisplatin and radiotherapy","volume":"89","author":"van de Vaart","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.lungcan.2008.11.014_bib9","first-page":"4899","article-title":"Transcription-coupled nucleotide excision repair as a determinant of cisplatin sensitivity of human cells","volume":"62","author":"Furuta","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.lungcan.2008.11.014_bib10","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0305-7372(98)90056-1","article-title":"Platinum-DNA adducts nucleotide excision repair and platinum based anti-cancer chemotherapy","volume":"24","author":"Reed","year":"1998","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.lungcan.2008.11.014_bib11","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/carcin\/21.3.453","article-title":"Nucleotide excision repair and human syndromes","volume":"21","author":"de Boer","year":"2000","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.lungcan.2008.11.014_bib12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0304-3835(00)00532-2","article-title":"The 399Gln polymorphism in the DNA repair gene XRCC1 modulates the genotoxic response induced in human lymphocytes by the tobacco-specific nitrosamine NNK","volume":"159","author":"Abdel-Rahman","year":"2000","journal-title":"Cancer Lett"},{"key":"10.1016\/j.lungcan.2008.11.014_bib13","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1078\/1438-4639-00294","article-title":"Use of biomarkers to characterize functions of polymorphic DNA repair genotypes","volume":"207","author":"Au","year":"2004","journal-title":"Int J Hyg Environ Health"},{"key":"10.1016\/j.lungcan.2008.11.014_bib14","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/ijc.21047","article-title":"Polymorphisms in DNA repair genes and epithelial ovarian cancer risk","volume":"114","author":"Auranen","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.lungcan.2008.11.014_bib15","first-page":"1513","article-title":"Polymorphisms in DNA repair genes and associations with cancer risk","volume":"11","author":"Goode","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.lungcan.2008.11.014_bib16","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.1158\/1078-0432.CCR-04-0247","article-title":"Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced nonsmall cell lung cancer patients treated with platinum-based chemotherapy","volume":"10","author":"Zhou","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.lungcan.2008.11.014_bib17","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S1525-7304(11)70205-4","article-title":"Impact of genetic polymorphisms in DNA repair enzymes on drug resistance in lung cancer","volume":"6","author":"Price","year":"2004","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.lungcan.2008.11.014_bib18","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.1158\/1078-0432.CCR-04-2657","article-title":"Association between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients","volume":"11","author":"Chang-Claude","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.lungcan.2008.11.014_bib19","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/carcin\/21.5.965","article-title":"Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells","volume":"21","author":"Duell","year":"2000","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.lungcan.2008.11.014_bib20","first-page":"2557","article-title":"XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency","volume":"59","author":"Lunn","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.lungcan.2008.11.014_bib21","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1476-4598-4-18","article-title":"ABCC5, ERCC2 XPA and XRCC1 transcript abundance levels correlate with cisplatin chemoresistance in non-small cell lung cancer cell lines","volume":"4","author":"Weaver","year":"2005","journal-title":"Mol Cancer"},{"key":"10.1016\/j.lungcan.2008.11.014_bib22","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/0092-8674(95)90289-9","article-title":"Mammalian DNA nucleotide excision repair reconstituted with purified protein components","volume":"80","author":"Aboussekhra","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.lungcan.2008.11.014_bib23","doi-asserted-by":"crossref","first-page":"16030","DOI":"10.1074\/jbc.272.25.16030","article-title":"The non-catalytic function of XPG protein during dual incision in human nucleotide excision repair","volume":"272","author":"Wakasugi","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.lungcan.2008.11.014_bib24","doi-asserted-by":"crossref","first-page":"167721681","DOI":"10.1093\/carcin\/bgg120","article-title":"Relationship between XPG codon 1104 polymorphism and risk of primary lung cancer","volume":"24","author":"Jeon","year":"2003","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.lungcan.2008.11.014_bib25","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1093\/carcin\/21.8.1527","article-title":"Reduced expression levels of nucleotide excision repair genes in lung cancer: a case\u2013control analysis","volume":"21","author":"Cheng","year":"2000","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.lungcan.2008.11.014_bib26","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1200\/jco.2004.22.14_suppl.3677","article-title":"XPD, XPA ERCC1 and XPG\/ERCC5 single nucleotide polymorphisms (SNPs) in oxaliplatin2treated colorectal cancer (CRC)","volume":"22","author":"Vila","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2008.11.014_bib27","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","article-title":"Reporting results of cancer treatment","volume":"47","author":"Miller","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2008.11.014_bib28","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1002\/elps.200500918","article-title":"An improved gel-based DNA microarray method for detecting single nucleotide mismatch","volume":"27","author":"Xiao","year":"2006","journal-title":"Electrophoresis"},{"key":"10.1016\/j.lungcan.2008.11.014_bib29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa060096","article-title":"A five-gene signature and clinical outcome in non-small-cell lung cancer","volume":"356","author":"Chen","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lungcan.2008.11.014_bib30","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1056\/NEJMoa011954","article-title":"Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer","volume":"346","author":"Schiller","year":"2002","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.lungcan.2008.11.014_bib31","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1200\/JCO.2001.19.13.3210","article-title":"Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small-cell lung cancer: a Southwest Oncology Group trial","volume":"19","author":"Kelly","year":"2001","journal-title":"J Clin Oncol"},{"issue":"21","key":"10.1016\/j.lungcan.2008.11.014_bib32","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1200\/JCO.2002.02.068","article-title":"Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer","volume":"20","author":"Scagliotti","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2008.11.014_bib33","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0169-5002(03)00233-2","article-title":"Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: a phase III randomized trial","volume":"41","author":"Zatloukal","year":"2003","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2008.11.014_bib34","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.pharmthera.2005.02.005","article-title":"Pharmacokinetics for individualized cancer chemotherapy","volume":"107","author":"Efferth","year":"2005","journal-title":"Pharmacol Therap"},{"key":"10.1016\/j.lungcan.2008.11.014_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0921-8777(99)00058-0","article-title":"XRCC1 keeps DNA from getting stranded","volume":"459","author":"Thompson","year":"2000","journal-title":"Mutat Res"},{"key":"10.1016\/j.lungcan.2008.11.014_bib36","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1200\/jco.2004.22.14_suppl.3677","article-title":"XPD, XPA, ERCC1 and XPG\/ERCC5 single nucleotide polymorphisms (SNPs) in oxaliplatin treated colorectal cancer (CRC)","volume":"22","author":"Vila","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2008.11.014_bib37","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1200\/JCO.2004.08.067","article-title":"XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum Chemotherapy","volume":"22","author":"Gurubhagavatula","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2008.11.014_bib38","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1158\/1078-0432.CCR-06-2543","article-title":"Prospective assessment of XPD Lys751Gln and XRCC1 Arg399Gln single nucleotide polymorphisms in lung cancer","volume":"13","author":"Giachino","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.lungcan.2008.11.014_bib39","doi-asserted-by":"crossref","first-page":"61325","DOI":"10.1002\/cncr.23312","article-title":"Multiple gene methylation of nonsmall cell lung cancers evaluated with 3-dimensional microarray","volume":"112","author":"Wang","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2008.11.014_bib40","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1016\/j.bios.2006.08.033","article-title":"Bisulfite modification of immobilized DNAs for methylation detection","volume":"22","author":"Wan","year":"2007","journal-title":"Biosensors and Bioelectronics"},{"key":"10.1016\/j.lungcan.2008.11.014_bib41","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1002\/elps.200600794","article-title":"Gel immobilization of acrylamide-modified single-stranded DNA template for pyrosequencing","volume":"28","author":"Xiao1","year":"2007","journal-title":"Electrophoresis"},{"key":"10.1016\/j.lungcan.2008.11.014_bib42","doi-asserted-by":"crossref","first-page":"8474","DOI":"10.1021\/bi00026a031","article-title":"Formation of DNA adducts by the anticancer drug carboplatin: different nucleotide sequence preferences in vitro and in cells","volume":"34","author":"Blommaert","year":"1995","journal-title":"Biochemistry"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500208006090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500208006090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T11:58:45Z","timestamp":1558094325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500208006090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S0169500208006090"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2008.11.014","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}